NASDAQ$ASTH

Astrana Health Inc · Q1 2024 earnings

Q1 2024 earnings · · Investor relations

Briefing

Reported strong first quarter performance driven by solid membership growth and successful management of total cost of care.

Astrana Health reported a strong first quarter with a 20% increase in revenue, a 13% increase in net income attributable to Astrana, and a 42% increase in adjusted EBITDA compared to the prior year quarter. This performance was primarily driven by solid membership growth across all lines of business and successful management of total cost of care for members. The total number of lives managed increased to approximately one million due to 10% organic membership growth year-to-date.

  • Revenue grew by 20% year-over-year.
  • Net income attributable to Astrana increased by 13% year-over-year.
  • Adjusted EBITDA grew by 42% year-over-year.
  • Organic membership growth of 10% year-to-date increased total lives managed to approximately one million.

Headline financials

Total Revenue

$404M

Previous: $337M+19.9%
EPS

$0.31

Previous: $0.28+10.7%
Adjusted EBITDA

$42.2M

No prior period
Adjusted EBITDA Margin

10.0%

No prior period
Capital Expenditures

-$369K

Previous: -$6.03M+93.9%
Free Cash Flow

$14.5M

Previous: $8.6M+68.3%
Net Income

$14.8M

Previous: $14.6M+1.5%
Operating Income

$30.1M

Previous: $22.4M+34.7%
Gross Profit

-$335M

Previous: -$293M-14.3%
Cash & Equivalents

$335M

Previous: $275M+21.9%
Total Assets

$1.23B

Previous: $993M+23.5%
Stock-Based Comp

$5.75M

Previous: $3.45M+66.9%

Revenue & EPS history

Astrana Health · Revenue · Quarterly

$404M

Q1 2024+19.9%vs Q1 2023
Beat estimate in 10 of 14 quarters(71%)
ActualEstimate

Forward guidance

Astrana is reiterating its guidance for total revenue, net income attributable to Astrana, Adjusted EBITDA, and EPS - diluted for the year ending December 31, 2024, based on the Company’s existing business, current view of existing market conditions and assumptions.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2024

Historical avgQ1 2024

+0.7%

Avg return

Earnings day

-2.1%

Avg return

5 days after

+2.1%

Avg return

30 days after

40%

23 / 57 earnings

Positive

+83.3%

Q3 2011

Best reaction

-40.5%

Q2 2012

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2025+29.4%+22.5%+20.6%
Q3 2025-23.4%-29.4%-33.8%
Q1 2025-11.1%-20.8%-24.5%
Q4 2024-26.8%+5.0%+16.1%
Q3 2024-21.1%-27.9%-30.4%
Q2 2024-1.4%-1.8%+0.1%
Q1 2024-0.7%+1.5%+8.0%
Q4 2023+2.3%+1.8%-1.9%
Q3 2023+9.3%+2.9%+13.4%
Q2 2023+4.2%+3.5%-17.4%
Q1 2023+5.4%+7.0%-0.8%
Q4 2022+6.9%+5.2%+15.2%
Q3 2022+8.4%+8.9%-14.5%
Q2 2022-4.3%-11.0%-29.3%
Q1 2022-0.5%-5.4%-26.4%
Q4 2021-2.0%-11.0%-7.0%
Q3 2021+14.7%+30.5%+0.8%
Q2 2021-11.8%-10.7%-12.9%
Q1 2021+4.5%+4.7%+10.9%
Q4 2020+9.1%+8.8%+8.3%
Q3 2020-1.2%-1.6%+0.5%
Q2 2020+1.8%+2.4%+7.9%
Q1 2020-10.4%-11.6%+13.1%
Q4 2019-12.9%-24.0%+7.0%
Q3 2019-2.9%-0.9%+25.0%
Q2 2019-5.0%+4.8%+31.1%
Q1 2019-1.2%-4.3%-29.7%
Q4 2018-6.4%-8.3%-6.9%
Q3 2018+26.3%+4.0%-4.6%
Q2 2018-13.7%-23.3%-32.2%
Q4 2017+10.8%-6.3%+2.1%
Q1 2018+10.8%-6.3%+2.1%
Q3 2017+3.9%+3.9%+140.0%
Q2 2017+0.0%+0.0%-10.5%
Q1 2017+0.0%+6.7%+36.7%
Q1 2016+4.0%+4.0%+0.0%
Q3 2016-4.8%
Q2 2016-12.9%
Q1 2015-6.5%
Q3 2015-3.2%
Q2 2015+0.0%
Q2 2014+15.6%
Q4 2013
Q3 2013+1.6%
Q2 2013+13.5%
Q1 2013-13.3%
Q4 2012-2.2%
Q3 2012-9.1%
Q2 2012-40.5%
Q1 2012+0.0%
Q4 2011
Q3 2011+83.3%
Q2 2011+0.5%
Q1 2011-0.5%
Q4 2010-3.9%
Q3 2010+19.0%
Q2 2010+0.0%
Q1 2010-2.1%
Q4 2009+9.9%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro